Therefore, it is tempting to speculate that the effects of allopurinol against CML cells reported here, may well be due to the reduction of ROS production, not only by XOR but also by NADPH oxidases. The gene discussed is FMO5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.